Details

DSEN Abstract: SGLT2 Inhibitors and the Risk of Major Adverse Cardiovascular Events - CIHR

Metadata and links for an archived snapshot.

Source
Canadian Institutes of Health Research
Date
Mar 10, 2026 · edition #8
Timestamp
2026-03-10T10:14:51.028Z
Language
en
ID
1040545
Status
200
Type
text/html

Independent archive · Not an official government website. For up-to-date recommendations, always consult the official source website.

Other snapshots

Archived page preview